Tradestie Institutional Equity Comparison Engine · Market Close Nov 17, 2026

SBRA vs GNL: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

SBRA Wins Head-to-Head Institutional Verdict (3–3 across 6 Pillars · 8–2 Matrix Metrics)

SBRA Overall Winner 6-Pillar Tally: SBRA 3 – 3 GNL Matrix Metrics: SBRA 8 – 2 GNL

As of Nov 17, 2026, Sabra Healthcare REIT, Inc. (SBRA) is the stronger overall head-to-head candidate over Global Net Lease, Inc. (GNL) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Options & Positioning). SBRA carries a Unified Composite Score of 57.4/100 (HOLD) at $20.25 (30.4x Forward P/E, 18.4% operating margin), whereas GNL carries 35.5/100 (SELL) at $6.28 (N/M Forward P/E, 34.8% operating margin).

  • Technical & Structure Timing Caution: SBRA trades in a Neutral technical trend (CONSOLIDATION options phase, RSI 50.8); meanwhile GNL is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 19.1). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About SBRA vs GNL
SBRA NASDAQ Head-to-Head Winner
Sabra Healthcare REIT, Inc.
Real Estate Investment Trusts
$20.25
-0.47% 1D
Market Cap $5.4B
TTM Revenue $924M
Forward P/E 30.4x
Beta / 30D Vol 0.00β · 30% Vol
Unified Composite Score
57.4 / 100 HOLD
Tech 49.0 Fund 57.0 Flow 57.0 Mom 64.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 51
RSI-14: 50.8 · SMA20: $20.21 · SMA50: $19.86
GNL NYSE
Global Net Lease, Inc.
Real Estate Investment Trusts
$6.28
-2.71% 1D
Market Cap $1.5B
TTM Revenue $452M
Forward P/E N/M
Beta / 30D Vol 0.21β · 29% Vol
Unified Composite Score
35.5 / 100 SELL
Tech 25.0 Fund 38.0 Flow 50.0 Mom 45.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -10.0%), weak momentum, RSI 19
RSI-14: 19.1 · SMA20: $6.92 · SMA50: $7.75

6-Pillar Scorecard Institutional Category Breakdown (SBRA 3 – 3 GNL)

Columns: Metric · SBRA · GNL
1. Valuation Multiples SBRA
Forward P/E 30.4x N/M
Trailing P/E 75.7x N/M
PEG Ratio 5.28x N/M
EV / Revenue 8.4x 3.2x
2. Growth & Scale SBRA
Revenue Growth (YoY) +31.6% -6.7%
Earnings Growth (YoY) +22.2% +333.0%
TTM Revenue (USD) $924M $452M
Market Cap $5.4B $1.5B
3. Profitability & Quality GNL
Gross Margin 49.6% 86.7%
Operating Margin 18.4% 34.8%
Net Profit Margin 7.7% -2.1%
Return on Equity (ROE) 2.5% -0.8%
4. Balance Sheet & Cash Flow GNL
Cash Generation (TTM) $401M $332M EBITDA
Cash Flow Margin 43.3% 73.5% EBITDA Mgn
Net Cash / Leverage $2.42B Net Debt (0.86x D/E) $6.91 Book/Sh · -0.8% ROE
Dividend Yield 5.92% 11.36%
5. Options & Positioning SBRA
Options Structure Phase CONSOLIDATION UNCLASSIFIED
Current IV / %ile 27.4% (17th %ile) 204.7% (100th %ile)
Put/Call OI Skew 0.19x (Call-Skewed) N/A
OBV Trend / Tech Phase DISTRIBUTION · Neutral NEUTRAL · Markdown
6. R&D & Supply-Chain Moat GNL
OpEx & R&D Intensity 31.2% of Rev ($288M) 51.9% of Rev ($234M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Scale & Operating Efficiency Moat High-Margin Pricing Power Moat
Supply-Chain Role REIT - Healthcare Facilities Operator REIT - Diversified Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: SBRA (8) vs GNL (2)
Institutional Metric SBRA GNL Criterion Row Edge
Market Capitalization
Scale
$5.4B $1.5B Larger Scale SBRA
Trailing P/E Ratio
Valuation
75.7x N/M Lower Multiple SBRA
Forward P/E Ratio
Valuation
30.4x N/M Lower Multiple SBRA
Revenue Growth (YoY)
Growth
+31.6% -6.7% Higher Growth SBRA
Operating Margin (TTM)
Profitability
18.4% 34.8% Higher Margin GNL
Net Profit Margin
Profitability
7.7% -2.1% Higher Margin SBRA
Return on Equity (ROE)
Capital Efficiency
2.5% -0.8% Higher ROE SBRA
52-Week Range Position
Momentum
52% ($18–$23) 1% ($6–$10) Stronger Trend SBRA
Beta / 30D Volatility
Risk Regime
0.00β · 30% Vol 0.21β · 29% Vol Lower Realized Risk GNL
Unified Institutional Score
Composite Signal
57.4 / 100 (HOLD) 35.5 / 100 (SELL) Higher Composite SBRA
Trailing 12M Revenue (USD)
Operating Scale
$924M $452M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
49.6% 86.7% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
5.28x PEG · 8.4x EV/Rev N/M PEG · 3.2x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$401M ($2.42B Net Debt (0.86x D/E)) $332M EBITDA ($6.91 Book/Sh · -0.8% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon SBRA +20.44 pp
SBRA: +6.16% · GNL: -14.28%
3M Horizon SBRA +28.97 pp
SBRA: -1.39% · GNL: -30.36%
6M Horizon SBRA +29.08 pp
SBRA: -3.59% · GNL: -32.67%
1Y Horizon SBRA +29.58 pp
SBRA: +8.61% · GNL: -20.97%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on SBRA vs GNL. Trailing 12-month operating profitability (SBRA 18.4% vs GNL 34.8%) and valuation multiples (SBRA 30.4x vs GNL N/M Forward P/E) are benchmarked directly in Pillar 4 below.

SBRA ADR TTM Benchmark FX-Normalized USD
TTM Revenue$924M
Gross Margin49.6%
Op. Margin18.4%
ROE / Fwd P/E2.5% · 30.4x
GNL ADR TTM Benchmark FX-Normalized USD
TTM Revenue$452M
Gross Margin86.7%
Op. Margin34.8%
ROE / Fwd P/E-0.8% · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
SBRA CONSOLIDATION
80d in phase · OBV DISTRIBUTION
Current IV 27.4%
IV Percentile 17th %ile
Put/Call OI Skew 0.19x (Call-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow DISTRIBUTION
Exact SBRA Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
GNL UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 204.7%
IV Percentile 100th %ile
Put/Call OI Skew N/A
IV Regime Extreme (>80th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact GNL Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
SBRA Moat Profile Scale & Operating Efficiency Moat
REIT - Healthcare Facilities Operator
Competes within the REIT - Healthcare Facilities value chain with $5.4B market capitalization and 18.4% operating margin.
OpEx & R&D Reinvestment 31.2% of Rev ($288M)
90D Engineering Disclosures 0 Published
GNL Moat Profile High-Margin Pricing Power Moat
REIT - Diversified Operator
Competes within the REIT - Diversified value chain with $1.5B market capitalization and 34.8% operating margin.
OpEx & R&D Reinvestment 51.9% of Rev ($234M)
90D Engineering Disclosures 0 Published

Investor FAQ SBRA vs GNL Key Questions & Quantitative Answers

As of Nov 17, 2026, Sabra Healthcare REIT, Inc. (SBRA) is the stronger overall head-to-head candidate over Global Net Lease, Inc. (GNL) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Options & Positioning). SBRA carries a Unified Composite Score of 57.4/100 (HOLD) at $20.25 (30.4x Forward P/E, 18.4% operating margin), whereas GNL carries 35.5/100 (SELL) at $6.28 (N/M Forward P/E, 34.8% operating margin). Technical & Structure Timing Caution: SBRA trades in a Neutral technical trend (CONSOLIDATION options phase, RSI 50.8); meanwhile GNL is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 19.1). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

SBRA leads the Growth & Scale pillar: SBRA posts +31.6% YoY revenue growth and +22.2% YoY earnings growth on $924M TTM revenue (49.6% gross margin, 18.4% operating margin), compared with GNL at -6.7% YoY revenue growth and +333.0% YoY earnings growth on $452M TTM revenue (86.7% gross margin, 34.8% operating margin). On trailing 12-month operating scale, SBRA generates $924M in USD-normalized revenue versus $452M for GNL. In operating R&D and SG&A reinvestment, SBRA deploys 31.2% of Rev ($288M) (0 90-day corporate R&D disclosures) versus 51.9% of Rev ($234M) (0 disclosures) for GNL.

SBRA screens cheaper on headline valuation multiples. SBRA trades at 30.4x Forward P/E, 75.7x Trailing P/E, 5.28x PEG, and 8.4x EV/Revenue (43.3% FCF margin), whereas GNL trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 3.2x EV/Revenue (73.5% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against SBRA (2.5% ROE) versus GNL (-0.8% ROE) capital efficiency.

In options market volatility and institutional positioning, SBRA carries 27.4% implied volatility (17th %ile, Compressed (<25th %ile)), a 0.19x (Call-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a CONSOLIDATION options structure phase (0.00β · 30% Vol realized risk). By comparison, GNL carries 204.7% implied volatility (100th %ile, Extreme (>80th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.21β · 29% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 17, 2026. For educational research only; not investment advice.